Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Two-Seventy-One Patent Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Two-Seventy-One Patent Blog"And We're Off!" - Companies Turning To Congress on Patent Reform Issues
By Peter Zura
Specifically, the letter comes out against post-grant review and argues that the PTO is not equipped to handle the inevitable flood of requests:
[T]these proposals represent a huge risk for the Patent and Trademark Office, which already is under severe strain as indicated in Congress? emergency approval to use trademark fees for patent functions. Adding new obligations to the agency at this time seems extraordinarily unwise. Almost inherently, the basic patent examination function will suffer, with the result of longer patent pendency and lower patent quality. . .
Another troubling aspect of the post-grant review and inter partes reexamination proposals is that, as written, they are vulnerable to a high level of abuse. Specifically, the current construct of the proposals will allow infringers to subject valid patents to lengthy and repeat challenges.
* * *
We agree on the goal of reducing the amount and cost of patent litigation. We do not believe, however, that the post-grant and inter partes provisions, as drafted, will achieve this goal. We urge you to push for improvements to these provisions which will limit the ability of infringers to undermine the very system the legislation attempts to strengthen.
Read/download the entire letter here (link)
See also, "Tech cos. protest patent reform in letter to Locke" (link)
Full post as published by Two-Seventy-One Patent Blog on September 20, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Texas, USA
alleging the Medical Malpractice and Tort Reform Act of 2003 violates several provisions of the Constitution.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Two Energy Companies Settle Whistleblower Qui Tam Suit
Two Energy Companies Settle Whistleblower Qui Tam Suit
Chemical Companies
alleging danger to people living near the plants.

Tech Companies Send Letter on Patent Reform to Secretary Locke
Patent reform 2009: least likely of the unlikely
Congress Tries To Move Ahead On Patent Reform - Again
CJ Michel: "If they get it a little wrong, it will do a lot of harm"
Hearing Today on H.R. 1260, the Patent Reform Act of 2009








